Skip to main content
DR REDDYS LABORATORIES LTD logo

DR REDDYS LABORATORIES LTD — Investor Relations & Filings

Ticker · RDY ISIN · US2561352038 LEI · 335800OVDPY3DVZR2798 BSE.NS Manufacturing
Filings indexed 2,323 across all filing types
Latest filing 2024-10-02 Regulatory Filings
Country IN India
Listing BSE.NS RDY

About DR REDDYS LABORATORIES LTD

https://www.drreddys.com/

Dr. Reddy's Laboratories Ltd. is an integrated global pharmaceutical company focused on providing affordable and innovative medicines. The company's core activities include the development, manufacturing, and marketing of a broad portfolio of products. This portfolio encompasses Active Pharmaceutical Ingredients (APIs), generic and branded-generic formulations, over-the-counter (OTC) products, and biologics. In addition to its significant presence in the generics market, the company invests in the research and development of novel molecules and proprietary products, with a focus on therapeutic areas such as dermatology and neurology. Dr. Reddy's is also committed to sustainable operations, actively working to reduce its environmental footprint through initiatives in water conservation, waste reduction, and decarbonisation.

Recent filings

Filing Released Lang Actions
FORM 6-K
Regulatory Filings
2024-10-02 English
Press Release
Regulatory Filings Classification · 95% confidence The document is a press release announcing a voluntary licensing agreement between Dr. Reddy's Laboratories and Gilead Sciences for the manufacture and commercialization of a drug. It contains no financial statements, regulatory certifications, or detailed financial data. It is an announcement of a corporate development rather than a financial report or regulatory filing. The document is not a report publication announcement since it does not mention any report being published or attached. It is not related to earnings, management changes, or legal proceedings. Therefore, the best fitting category is a Regulatory Filing (RNS) as a general announcement that does not fit other specific categories.
2024-10-02 English
FORM 6-K
Regulatory Filings
2024-10-02 English
Disclosure under Regulation 30 of SEBI (LODR) Regulations, 2015
Regulatory Filings Classification · 95% confidence The document is a disclosure under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, regarding the dissolution of a step-down wholly owned overseas subsidiary. It provides details about the subsidiary's dissolution and confirms that it is not material to the company. The document is an official announcement to stock exchanges and does not contain financial statements or detailed financial analysis. It is a regulatory announcement about a corporate event (subsidiary dissolution) rather than a financial report or management discussion. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2024-10-01 English
FORM 6-K
Regulatory Filings
2024-09-30 English
Disclosure under Regulation 30 of SEBI (LODR) Regulations, 2015
Capital/Financing Update Classification · 95% confidence The document is an intimation under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, regarding the completion of an acquisition by Dr. Reddy's Laboratories. It provides details about the acquisition transaction, including payment and subsidiaries involved. The document is addressed to stock exchanges and is a formal announcement of a corporate event (completion of acquisition). It does not contain financial statements, detailed financial analysis, or full report content. The document length is 3160 characters, which is relatively short and consistent with an announcement rather than a full report. Therefore, this document fits the category of Capital/Financing Update (CAP), which covers updates on company fundraising, financing activities, or capital structure changes such as acquisitions.
2024-09-30 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.